Servier Doubles Up on Digital Twin Alliance with Aitia
The new project will focus on pancreatic cancer, and builds on a collaboration in the blood cancer multiple myeloma that was started by the two companies last year. Read more on the latest collaboration between Servier and Aitia, in Pharmaphorum article. Full article here. Picture Credit: Pharmaphorum
Join Aitia at the Symposium on Risks and Opportunities of AI in Pharmaceutical Medicine – AIPM 2023
Join us at the Symposium on Risks and Opportunities of AI in Pharmaceutical Medicine on June 5, sponsored by Pfizer Inc., the Roux Institute at Northeastern University, and the American Statistical Association (ASA). At Aitia, we are excited to present a session entitled “Causal AI for Learning ‘Digital Twins’ from Human Multi-Omic Data for Drug […]
Meet us at Bio-IT World Conference in Boston
We are thrilled to announce that Joe Donahue will be chairing a session entitled “Discover Novel Drug Candidates to Produce Better Precision Medicines” at the Bio-IT World Conference on May 18th at 10:20 ET, as part of the “AI for Drug Discovery and Development” track. The AI for Drug Discovery and Development track is an […]
Join Aitia at Charles River’s sixth Annual World Congress
We are excited to announce that Colin Hill will be speaking at Charles River’s sixth Annual World Congress on May 11, 2023, in Cambridge, MA. Colin’s session will focus on “Al and Digital Twins to Drive the Next Generation of Drug Discovery and Development”. The presentation will be followed by a fireside chat with Julie […]
Join Aitia and our Partner GAP at the American Academy of Neurology Annual Meeting 2023
We are excited to announce our attendance at the American Academy of Neurology Annual Meeting 2023, which will be held in Boston. As we look forward to this event, we are also pleased to be joined by our strategic partner the Global Alzheimer’s Platform Foundation (GAP). Together, we are committed to advancing the field of […]
Join Aitia at the Pistoia Alliance Annual Spring Conference
We are excited to be attending the Pistoia Alliance Annual Spring Conference. This year’s theme is Collaborate to Innovate, and we can’t wait to explore the opportunities for pre-competitive collaboration in the life sciences industry. Let’s connect and discuss the challenges and possibilities for innovation and AI adoption in R&D. Come meet us there and […]
Companies to Focus on Therapeutic Targets Showing Cause and Effect
Aitia has been featured in Huntington’s Disease News for its collaboration with UCB to develop a new treatment for Huntington’s disease. The article highlights Aitia’s expertise in Causal AI as “a new branch of artificial intelligence that goes beyond establishing links between variables: It makes decisions and predictions based on cause and effect.” The collaboration […]
UCB Enters Drug Discovery Collaboration with Aitia
Aitia latest strategic drug discovery collaboration with UCB, focused on the discovery and validation of novel drug targets and drug candidates for Huntington’s disease. The collaboration will combine the use of new drug targets for Huntington’s disease from Aitia’s Gemini Digital Twins with the expertise of UCB in preclinical model systems and drug research in neurodegeneration for advancing […]
Aitia Announces Oral Poster Presentation and Abstract at AACR
Aitia is looking forward to attend this year’s American Association for Cancer Research meeting #AACR23 taking place in Orlando, Florida, on April 14-19. Our team will be presenting a poster with our new results from our Multiple Myeloma Digital Twins model. Details of the poster session: Title: Infer cancer cell gene dependency in multiple myeloma using causal AI in-silico patient […]
Aitia Announces its Participation in the Upcoming AD/PD™ 2023 in Gothenburg, Sweden
Aitia is excited to announce its participation in the upcoming AD/PD™ 2023, a global conference on Alzheimer’s and Parkinson’s Diseases, to be held in Gothenburg, Sweden from March 28 – April 1.If you are interested in learning more about Aitia’s latest breakthroughs, particularly in the field of Alzheimer’s disease, we encourage you to schedule a […]